Silvia Mateo‐Lozano

发表

Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases.

L. Meijer, J. Endicott, M. Kubbutat, 2007, Cancer research.

Combined Transcriptional and Translational Targeting of EWS/FLI-1 in Ewing's Sarcoma

V. Soldatenkov, V. Notario, A. Dritschilo, 2006, Clinical Cancer Research.

Targeted Therapies in Sarcomas: Challenging the Challenge

X. García del Muro, Ò. M. Tirado, J. Martín Liberal, 2012, Sarcoma.

Roscovitine is an effective inducer of apoptosis of Ewing's sarcoma family tumor cells in vitro and in vivo.

V. Notario, Ò. M. Tirado, Silvia Mateo‐Lozano, 2005, Cancer research.

Brush border Myosin Ia has tumor suppressor activity in the intestine

M. Kloor, L. Aaltonen, D. Arango, 2012, Proceedings of the National Academy of Sciences.

Parathyroid hormone‐like hormone plays a dual role in neuroblastoma depending on PTH1R expression

J. Mora, Marta García, C. Lavarino, 2019, Molecular oncology.

Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System

Marta García, C. de Torres, C. J. Rodriguez-Hernandez, 2016, Front. Physiol..

Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue.

Philippe Bernard, Florence Popowycz, Laurent Meijer, 2009, Journal of medicinal chemistry.

The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.

Andrew J. Wilson, D. Arango, J. Mariadason, 2009, Cancer research.

Brush border myosin Ia inactivation in gastric but not endometrial tumors

D. Arango, R. Hofstra, J. Mariadason, 2013, International journal of cancer.

Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment

Andrew J. Wilson, D. Arango, J. Mariadason, 2010, Clinical Cancer Research.

Targeting EWS/FLI1 Driven Signaling Pathways as Therapy for Tumors of the Ewing’s Sarcoma Family

V. Notario, Silvia Mateo-Lozano, Vicente Notario, 2010 .

Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.

J. Ban, H. Kovar, V. Notario, 2006, Cancer research.

Tumorigenicity of Ewing ' s Sarcoma Cells Determinant of the Oncogenic Phenotype and ) Is a Target of EWS / FLI-1 and a Key CAV 1 Caveolin-1 ( Updated

J. Ban, H. Kovar, V. Notario, 2006 .

RHOA inactivation enhances Wnt signaling and promotes colorectal cancer

John M. Mariadason, Josep Tabernero, D. Arango, 2014, Nature Communications.

Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation

V. Notario, Ò. M. Tirado, Silvia Mateo‐Lozano, 2003, Oncogene.

The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing’s sarcoma

V. Notario, Aniruddha Sengupta, Ò. M. Tirado, 2013, International journal of oncology.

Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize

V. Notario, C. Rodríguez-Galindo, F. Navid, 2010, Molecular Cancer Research.

Loss of the EPH receptor B6 contributes to colorectal cancer metastasis

D. Arango, J. Mariadason, S. Schwartz, 2017, Scientific Reports.

Caveolin-1 in sarcomas: friend or foe?

X. G. Del Muro, Ò. M. Tirado, M. Sáinz-Jaspeado, 2011, Oncotarget.

EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1

J. Mora, E. de Álava, X. G. Del Muro, 2013, PloS one.

The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation.

V. Notario, L. Dettin, Ò. M. Tirado, 2003, Cancer research.

Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity

V. Notario, Ò. M. Tirado, Silvia Mateo‐Lozano, 2005, Oncogene.

Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth

M. Esteller, J. Mora, S. Moran, 2014, Oncotarget.

Caveolin‐1 promotes resistance to chemotherapy‐induced apoptosis in Ewing's sarcoma cells by modulating PKCα phosphorylation

C. MacCarthy, N. Fatima, Ò. M. Tirado, 2010, International journal of cancer.

Auto-stimulatory action of secreted caveolin-1 on the proliferation of Ewing's sarcoma cells.

V. Notario, Aniruddha Sengupta, Ò. M. Tirado, 2011, International journal of oncology.

KDM6 demethylases mediate EWSR1-FLI1-driven oncogenic transformation in Ewing Sarcoma

Nicolò Riggi, J. Mora, E. Blanco, 2023, bioRxiv.

Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens

J. Mora, Marta García, Ferran Briansó, 2016, Oncotarget.

Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway

D. Herrero-Martín, S. Rello-Varona, C. Rodríguez-Galindo, 2016, Oncotarget.

AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia

J. Mora, Marta García, C. Lavarino, 2022, International journal of molecular sciences.

Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens

J. Mora, C. Lavarino, A. Carcaboso, 2016 .

Brush border Myosin Ia has tumor suppressor activity in the intestine

M. Kloor, L. Aaltonen, D. Arango, 2012, Proceedings of the National Academy of Sciences.